To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Additional recommended knowledge
NanoInk, Inc. is an emerging growth nanotechnology company headquartered in Skokie, IL, with a MEMS fabrication facility in Campbell, CA. A spin-off of Northwestern University and founded by Northwestern professor Chad Mirkin, NanoInk specializes in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology that allows for unmatched flexibility, accuracy and also its high-resolution Nanoencryption™ technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.
Brand Protection, Anti-Counterfeiting, and Nanoencryption™
NanoInk's website states that counterfeiting is a worldwide issue with almost anything of value in the marketplace at risk. According to the World Health Organization (WHO), ten percent of the world's pharmaceuticals are counterfeit . In Russia, twelve percent are fake, in Mexico, forty percent, and in Nigeria, up to eighty percent. Additionally, fifty percent of all drugs purchased on the internet are fake.
More than $35 billion in pharmaceutical revenue and $40 billion in aircraft parts revenue is lost each year to counterfeiting. Beyond the usual currency and luxury watches, counterfeit drugs affect not only manufacturers and retailers—the practice also can have damaging effects on the health and safety of the consumer:
Pharmaceutical diversion is a subset of Illegal diversion (or parallel trade) of goods, which is a global issue that causes significant revenue losses for manufacturers. Products are sold to wholesalers in other countries at discounted prices. A diverter then sells the cheaper product to another country's wholesaler at a price that provides them a profit, but also allows the original wholesaler to undercut the fair market value. The manufacturer loses the revenue differential between the discounted price it was sold for to the original wholesaler and the final fair market value.
NanoInk has developed a unique anti-counterfeiting and illegal diversion solution to combat this problem: Nanoencryption™ technology. NanoInk's proprietary Nanoencryption™ technology process provides for full authentication and traceability of a product, at the unit level, throughout its supply chain. According to NanoInk, each individual pharmaceutical tablet will be equipped with Nanoencryption™ technology.
The practice of counterfeiting and illegal diversion affects products beyond pharmaceuticals, including the authenticity of currency, auto and aircraft parts, medical devices, ID cards, consumer and luxury goods, software, tobacco, electronic parts and more. NanoInk has targeted pharmaceuticals first, but is now extending its Nanoencryption™ technology to other highly counterfeited industries. In addition to pharmaceuticals, counterfeiting of aircraft parts has a direct impact on consumer safety:
NanoInk's proprietary Nanoencryption™ technology provides a unit level solution to the problem of counterfeiting.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "NanoInk". A list of authors is available in Wikipedia.|